BFM Podcast

Betting the House on Tocotrienol

Tan KW
Publish date: Tue, 09 Sep 2014, 11:57 AM
Tan KW
231,678

David Ho, Hovid

09-Sep-14 10:55

In this 2014 interview, David Ho, Chairman and Managing Director of the pharmaceuticals firm Hovid Berhad, discusses global M&A fever in Big Pharma, offers an update on its latest quarterly earnings, its product mix, ongoing industry drivers and challenges and the importance of its ongoing R&D efforts such as its Tocotrienol drug.

Related Stocks
Market Buzz
Discussions
2 people like this. Showing 0 of 0 comments

Post a Comment